Taken together, these results indicated that abrogation of TGFβ signaling led to increased expression and activation of IRS-1 in colon cancer cells in vivo, suggesting that TGFβ may regulate IRS-1 expression and activation. Here, IRS1 is linked to malignant colon neoplasm.